货号:A888571 同义名: 4-Iodo-6-phenylpyrimidine
4-IPP是一种巨噬细胞迁移抑制因子 (MIF) 的特异性自杀底物和不可逆抑制剂,抑制NF-κB配体(RANKL)诱导的破骨细胞的受体激活剂,并在体外增强成骨细胞介导的矿化和骨结节的形成。
There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Migration inhibitory factor (MIF) is a pleiotropic inflammatory mediator that inhibits macrophage migration in innate and adaptive immunologic responses. 4-IPP is an irreversible MIF inhibitor that binds covalently to MIF to inhibit its activity. It inhibited the viability of bone marrow macrophages (BMMs) with an IC50 value of 104.3µM at 72h. 4-IPP at 5-20µM suppressed the formation of TRAP-positive multinucleated osteoclasts in a dose-dependent manner. 4-IPP treatment at a dose of 20µM also significantly downregulated the expression of genes involved in BMM precursor fusion (i.e. DC-STAMP), osteoclast maturation (i.e. c-Fos and NFATc1), and bone resorption (i.e. TRAP and CTSK) in BMM-derived osteoclasts. Osteoclasts-treated with 20µM 4-IPP resorbed 3.73±1.24% of the bone discs, whereas the untreated cells resorbed >40% of the total bone area. Incubation of BMMs with 20µM 4-IPP inhibited RANKL-induced NF-κB activation, resulting in the suppression of NFATc1 induction. Treatment with 20µM 4-IPP for 5 days suppressed the formation of TRAP-positive multinucleated osteoclasts in BMMs extracted from wild-type mice but not MIF knockout BMMs. Subcutaneous injection of 4-IPP at a dose of 1 or 5mg/kg every 2 days for 2 weeks reduced the extent of Ti particle-induced bone destruction in mice. Administration of 4-IPP at 1 or 5mg/kg also alleviated the bone loss associated with estrogen deficiency in a mouse model of ovariectomy-induced osteoporosis[1]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.55mL 0.71mL 0.35mL |
17.73mL 3.55mL 1.77mL |
35.45mL 7.09mL 3.55mL |
CAS号 | 41270-96-6 |
分子式 | C10H7IN2 |
分子量 | 282.08 |
别名 | 4-Iodo-6-phenylpyrimidine |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Keep in dark place,Inert atmosphere,Store in freezer, under -20°C |
溶解方案 |
DMSO: 105 mg/mL(372.23 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
动物实验配方 |